PFE News and Press, Pfizer Inc.

2026-02-27 23:12:00 ET Introduction The Dividend Champions list is a monthly compilation of companies that have consistently increased their annual dividend payouts. However, since this list is only produced once per month, the data in it can quickly get out of date. Furthermore, wi...

2026-02-27 11:38:24 ET More on Merck Health Care Q4 Dividend Roundup: Merck Offers Thicker Dividend Cushion Than AbbVie Merck: Why Investors Should Remain Bullish Despite Patent Risks Merck: Keytruda Remains Resilient Despite LOE Risks - Buy Upon Correction F...

In the Phase 3 EV-304 trial, statistically significant improvements in overall survival and pathological complete response were also observed, with over half of patients having no detectable disease at surgery The results, combined with the recent unprecedented data from the EV-303 trial,...

2026-02-27 09:40:41 ET Company Background Beam Therapeutics Inc. ( BEAM ) was founded by David Liu, J. Keith Joung, and Feng Zhang in 2017. Its headquarters and research hub are in Cambridge, MA, while its manufacturing hub is in Durham, NC. It is one of several gene-edi...

2026-02-27 02:54:16 ET Shares of antisense therapy concern Ionis Pharmaceuticals, Inc. ( IONS ) have rallied strongly since its familial chylomicronemia syndrome med Tryngolza (olezarsen) bore strong data treating severe hypertriglyceridemia. Announced in September 2025, the res...

2026-02-26 14:36:15 ET More on Bayer Bayer Aktiengesellschaft (BAYRY) Discusses Roundup Class Settlement Agreement and Implications for U.S. Glyphosate Litigation Transcript Bayer Aktiengesellschaft (BAYRY) Discusses OCEANIC-STROKE Phase III Results and Asundexian in Seconda...

2026-02-26 13:35:52 ET More on leading drugmakers Health Care Q4 Dividend Roundup: Merck Offers Thicker Dividend Cushion Than AbbVie Johnson & Johnson: Strong Run May Be Ending (Rating Downgrade) Merck: Why Investors Should Remain Bullish Despite Patent Risks ...

2026-02-26 12:27:26 ET More on Pfizer, BioNTech, etc. BioNTech: The Market Is Pricing Low Oncology Success Pfizer: A Risky 6.3% Yield For Income-Oriented Investors Q4 Healthcare Dividends: Johnson & Johnson Kept Outshining Pfizer (Rating Upgrades) Novavax...

2026-02-26 09:11:45 ET More on markets S&P 500’s 20-day range squeeze near highs hints at imminent shift Powell may remain at the helm as traders shift Warsh confirmation timeline to the summer ETFs heavily tied to Nvidia prepare for potential volatility...

2026-02-26 07:48:01 ET Foreword While most of this collection of Barron's Better Bets ((BBB)) is too pricey, or reveal somewhat skinny dividends, five of the twelve highest yield Dogs with the "Safest" dividends of the BBB are ready to buy. February finds Pfizer ( PFE ),...